U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07366372) titled 'Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients' on Jan. 17.
Brief Summary: This study aimed to assess effectiveness of a taurolidine based lock solution in preventing the infections of central venous catheter (CVC) in intensive care unit (ICU) cases.
Study Start Date: May 01, 2023
Study Type: INTERVENTIONAL
Condition:
Taurolidine
Lock Solution
Prevention
Central Venous Catheter Infection
Intensive Care Unit
Intervention:
DRUG: Saline
Central venous catheters (CVCs) were locked with 2ml saline as a control group.
DRUG: Tigecycline and heparin
Central venou...